Home › Products › Oncology › Nextnib 20mg Tablet
Nextnib 20mg Tablet
Salt Composition: DASATINIB
- Manufacturer: CELON LABORATORIES LTD
- Pack Size: 60 TABLET(s) IN A BOTTLE
- Dosage Form: TABLET
- Strength: 20MG
- Prescription Required
- Storage: Store protected from light at a temperature not exceeding 30c.
₹1137.00₹1406.25
Inclusive of all taxes
Product Introduction
Nextnib 20mg Tablet contains Dasatinib as its active ingredient, which defines the Nextnib 20mg composition and its role as a targeted cancer therapy. It is prescribed for adults and children above 1 year of age for the treatment of certain blood cancers, including Philadelphia chromosome-positive (Ph+) Chronic Myeloid Leukemia (CML) and Ph+ Acute Lymphoblastic Leukemia (ALL) in specific cases.
Nextnib 20mg for leukemia works by targeting abnormal proteins produced due to changes in the Philadelphia chromosome, helping control the uncontrolled growth of cancerous blood cells. Chronic Myeloid Leukemia is a type of blood cancer where abnormal white blood cell production increases rapidly, while Acute Lymphoblastic Leukemia occurs when abnormal lymphocytes multiply quickly and interfere with the production of healthy blood cells.
The recommended Nextnib 20mg dosage for adults is determined by the treating oncologist after considering factors such as the stage of cancer, previous treatments, overall health condition, and response to therapy. Treatment decisions should always be made under medical supervision. When comparing options such as Nextnib 20mg vs Dasanat 20mg, doctors usually consider factors like effectiveness, patient response, safety profile, and individual treatment requirements rather than focusing only on price.
Common Nextnib 20mg side effects may include diarrhoea, headache, cough, skin rash, nausea, vomiting, tiredness, muscle pain, weakness, reduced appetite, and changes in blood pressure. Patients should inform their healthcare provider if any side effects continue, worsen, or become difficult to manage.
Uses
Nextnib 20mg uses is indicated for the following conditions: Children and adults with chronic myeloid leukemia. Adults with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) with resistance to prior therapy.
How it works
Nextnib 20mg tablet works by preventing the abnormal protein from signaling the growth of cancer cells. This aids in preventing or reducing the spread of cancer cells.
How to Use
Take the tablet with or without food at the same time each day. Do not break, crush or chew the tablet. Your doctor will decide the dose and frequency of administration of Nextnib 20mg tablet based on your disease severity and other factors. Do not stop taking the tablet without consulting your healthcare professional.
Side Effects
Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them. Nextnib 20mg side effects are Serious Unusual bleeding or bruising Rapid heart rate Changes in consciousness or speech Breathlessness and swelling all over the body Fever or signs of infection Fluid retention Heart problems Myelosuppression Severe allergic reaction Common Diarrhea Headache Cough Rash Nausea, tiredness, vomiting Muscle pain, weakness Low appetite High or low BP
References
- Bristol-Myers Squibb Pharma, Electronic Medicines Compendium (EMC), [Revised on Mar 2022] [Accessed on 1st Dec 2022], https://www.medicines.org.uk/emc/files/pil.7745.pdf
- Bristol-Myers Squibb Company, [Revised on Jun 2021] [Accessed on 1st Dec 2022], https://packageinserts.bms.com/ppi/ppi_sprycel.pdf
- H.G. Watson, J.I.O. Craig, L.M. Manson, Blood disease, Davidsonâs Principles and Practice of Medicine, 22nd Edition, 2014, 989-1056.
- Edward Chu, Cancer Chemotherapy, Langeâs Basic and Clinical Pharmacology, 14th Edition, 2018, 948-976.
Safety Advice
Pregnancy: unsafe Nextnib 20mg tablet is not recommended to use during pregnancy unless clearly necessary. Your physician will discuss the potential risk during pregnancy. Women should use effective birth control during treatment and 30 days after the final dose.
Lungs: Consult your doctor It is unknown whether Nextnib 20mg is safe to administer in patients with lung problems. Inform your physician if you have any lung disease before starting the treatment.
Breastfeeding: unsafe It is not recommended to breastfeed while taking Nextnib 20mg tablet as it is not known whether this medication passes into breast milk. You should not breastfeed during treatment and for 2 weeks after your final dose.
Disclaimer
The information provided on this page is intended for general informational purposes only and should not be considered as medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication. Self-medication can be harmful. Med For Rare does not endorse self-diagnosis or self-treatment.